# Episode 204 - Samir Ounzain - Co-founder & CEO Haya Therapeutics

Page: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics
Text version: https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics.md
Podcast: [The BioHub - by Avetix](https://stenobird.com/podcast/the-biohub-by-avetix-7252289)
Published: 2026-07-20T13:37:33+00:00
Episode link: https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-204---Samir-Ounzain---Co-founder--CEO-Haya-Therapeutics-e3mac0f
Audio file: https://anchor.fm/s/f0076084/podcast/play/123071951/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-6-20%2F428278780-44100-2-8aa25eeb10475.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics
Duration seconds: 1740

## Resource

In this episode of The BioHub by Avetix, I'm joined by Samir Ounzain , CEO and Co-Founder of HAYA Therapeutics . Samir shares the journey from pioneering research into the so-called "dark genome" to building one of biotech's most exciting RNA therapeutics companies. We discuss why long non-coding RNAs could unlock an entirely new class of precision medicines, the challenge of turning groundbreaking science into a business, and how HAYA is approaching diseases with significant unmet need. We also explore the importance of resilience in biotech, the evolution from scientist to CEO, the role AI is beginning to play in drug discovery, and what the future holds for RNA therapeutics and precision medicine.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-204-samir-ounzain-co-founder-ceo-haya-therapeutics.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.